Cargando…

Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer

PURPOSE: This study was planned to investigate the anti-breast-cancer property of acidic exopolysaccharide produced from marine Bacillus amyloliquefaciens 3MS 2017 (BAEPS) in an animal model, which previously showed in-vitro anti-breast-cancer activity, by studying its potential participation in var...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Abeer Y, Youness, Eman R, Mahmoud, Manal G, Asker, Mohsen S, El-Newary, Samah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984436/
https://www.ncbi.nlm.nih.gov/pubmed/32047357
http://dx.doi.org/10.1177/1178223420902075
_version_ 1783491652149575680
author Ibrahim, Abeer Y
Youness, Eman R
Mahmoud, Manal G
Asker, Mohsen S
El-Newary, Samah A
author_facet Ibrahim, Abeer Y
Youness, Eman R
Mahmoud, Manal G
Asker, Mohsen S
El-Newary, Samah A
author_sort Ibrahim, Abeer Y
collection PubMed
description PURPOSE: This study was planned to investigate the anti-breast-cancer property of acidic exopolysaccharide produced from marine Bacillus amyloliquefaciens 3MS 2017 (BAEPS) in an animal model, which previously showed in-vitro anti-breast-cancer activity, by studying its potential participation in various targeted mechanisms. METHODS: Mammary carcinoma in female Sprague-Dawley rats, both in prophylactic and in curative designs, was chemically induced using 7,12-dimethylebenz-(a)-anthracene (DMBA). B. amyloliquefaciens 3MS 2017 anti-breast-cancer property was evaluated by studying its effects on cancer-growth-rate-limiting enzymes (aromatase and Na(+)/K(+) ATPase), sexual hormones (estrogen and progesterone), antioxidant and inflammatory biomarkers (cyclooxygenase-1; COX-1 and cyclooxygenase-2; COX-2). The incidence of breast cancer by DMBA was dependent on the level of carcinoembryonic antigen (CEA) and aromatase. RESULTS: 7,12-Dimethylebenz-(a)-anthracene female rats were characterized by a significant increase in cancer-related biomarkers with an increase of oxidative stress biomarkers, in comparison with the negative control. Potent BAEPS anticancer activity on DMBA rats was exhibited either as a prophylactic or as a curative agent, which appeared via restoring the aromatase and Na(+)/K(+) ATPase subunits levels and CEA close to the normal level. Besides, BAEPS modulated a sexual hormone, in comparison with the cancer control group (P ⩽ .05). B. amyloliquefaciens 3MS 2017 selectively inhibited COX-2 in parallel with promising antioxidant properties. The curative characters of BAEPS were more promising than the prophylactic. CONCLUSION: The anti-breast-cancer characters accompanied with a good safety margin may be attributed to its inhibitory effect on cancer-growth-rate-limiting enzymes, estrogen production, COX-2 level and lipid peroxidation, concurrent with enhancing COX-1 level, progesterone production, and antioxidant status.
format Online
Article
Text
id pubmed-6984436
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-69844362020-02-11 Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer Ibrahim, Abeer Y Youness, Eman R Mahmoud, Manal G Asker, Mohsen S El-Newary, Samah A Breast Cancer (Auckl) Original Research PURPOSE: This study was planned to investigate the anti-breast-cancer property of acidic exopolysaccharide produced from marine Bacillus amyloliquefaciens 3MS 2017 (BAEPS) in an animal model, which previously showed in-vitro anti-breast-cancer activity, by studying its potential participation in various targeted mechanisms. METHODS: Mammary carcinoma in female Sprague-Dawley rats, both in prophylactic and in curative designs, was chemically induced using 7,12-dimethylebenz-(a)-anthracene (DMBA). B. amyloliquefaciens 3MS 2017 anti-breast-cancer property was evaluated by studying its effects on cancer-growth-rate-limiting enzymes (aromatase and Na(+)/K(+) ATPase), sexual hormones (estrogen and progesterone), antioxidant and inflammatory biomarkers (cyclooxygenase-1; COX-1 and cyclooxygenase-2; COX-2). The incidence of breast cancer by DMBA was dependent on the level of carcinoembryonic antigen (CEA) and aromatase. RESULTS: 7,12-Dimethylebenz-(a)-anthracene female rats were characterized by a significant increase in cancer-related biomarkers with an increase of oxidative stress biomarkers, in comparison with the negative control. Potent BAEPS anticancer activity on DMBA rats was exhibited either as a prophylactic or as a curative agent, which appeared via restoring the aromatase and Na(+)/K(+) ATPase subunits levels and CEA close to the normal level. Besides, BAEPS modulated a sexual hormone, in comparison with the cancer control group (P ⩽ .05). B. amyloliquefaciens 3MS 2017 selectively inhibited COX-2 in parallel with promising antioxidant properties. The curative characters of BAEPS were more promising than the prophylactic. CONCLUSION: The anti-breast-cancer characters accompanied with a good safety margin may be attributed to its inhibitory effect on cancer-growth-rate-limiting enzymes, estrogen production, COX-2 level and lipid peroxidation, concurrent with enhancing COX-1 level, progesterone production, and antioxidant status. SAGE Publications 2020-01-24 /pmc/articles/PMC6984436/ /pubmed/32047357 http://dx.doi.org/10.1177/1178223420902075 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Ibrahim, Abeer Y
Youness, Eman R
Mahmoud, Manal G
Asker, Mohsen S
El-Newary, Samah A
Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title_full Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title_fullStr Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title_full_unstemmed Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title_short Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
title_sort acidic exopolysaccharide produced from marine bacillus amyloliquefaciens 3ms 2017 for the protection and treatment of breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984436/
https://www.ncbi.nlm.nih.gov/pubmed/32047357
http://dx.doi.org/10.1177/1178223420902075
work_keys_str_mv AT ibrahimabeery acidicexopolysaccharideproducedfrommarinebacillusamyloliquefaciens3ms2017fortheprotectionandtreatmentofbreastcancer
AT younessemanr acidicexopolysaccharideproducedfrommarinebacillusamyloliquefaciens3ms2017fortheprotectionandtreatmentofbreastcancer
AT mahmoudmanalg acidicexopolysaccharideproducedfrommarinebacillusamyloliquefaciens3ms2017fortheprotectionandtreatmentofbreastcancer
AT askermohsens acidicexopolysaccharideproducedfrommarinebacillusamyloliquefaciens3ms2017fortheprotectionandtreatmentofbreastcancer
AT elnewarysamaha acidicexopolysaccharideproducedfrommarinebacillusamyloliquefaciens3ms2017fortheprotectionandtreatmentofbreastcancer